offering a potential breakthrough in Alzheimer’s treatment. Research from the College of Medicine provides promising insights ...

A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and more, play a significant role in disease-related bacterial presence. This ...

Currently, in the US, the lifetime risk of developing the disease is around one in 24. Research is still ongoing into exactly ...

After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.

Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson’s disease, which in the future may serve as a target for developing new treatments for this terrible ...

better predict disease treatment response for patients, and even speed up clinical trials. Our synthetic hydrogels create a breakthrough environment for human immune organoids, allowing us to model ...

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.